NCT00381017View on ClinicalTrials.gov

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2006

Conditions
Hepatitis CLiver CirrhosisHIV Infections
Interventions
DRUG

Peg interferon alpha-2b

Sponsors
All Listed Sponsors
collaborator

Integrated Therapeutics Group

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00381017 - Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) | Biotech Hunter | Biotech Hunter